InMode Ltd. receives Investment Bank Analyst Rating Update
Investing.com - InMode reported on Tuesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations. InMode announced earnings per share of $0.66...
InMode Ltd. (INMD) reported Q3 EPS of $0.66, $0.13 better than the analyst estimate of $0.53. Revenue for the quarter came in at $121.2 million versus the consensus estimate of...
-- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for the fourth quarter...
The U.S. government has started sending out the third round of direct stimulus checks to eligible Americans. For those readers who have decided to invest some or all of the...
Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
|Average||50.40 (+39.23% Upside)|
|No. of Analysts||5|